Colgate-Palmolive (NYSE:CL) Shares Sold by FSA Wealth Management LLC

FSA Wealth Management LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 17.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,649 shares of the company’s stock after selling 343 shares during the quarter. FSA Wealth Management LLC’s holdings in Colgate-Palmolive were worth $150,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Barclays PLC lifted its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. Te Ahumairangi Investment Management Ltd grew its holdings in Colgate-Palmolive by 2.5% in the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 43,957 shares of the company’s stock worth $4,537,000 after buying an additional 1,060 shares in the last quarter. Chelsea Counsel Co. increased its stake in Colgate-Palmolive by 10.0% during the 3rd quarter. Chelsea Counsel Co. now owns 5,500 shares of the company’s stock valued at $571,000 after buying an additional 500 shares during the period. Fulcrum Equity Management lifted its position in Colgate-Palmolive by 3.0% in the third quarter. Fulcrum Equity Management now owns 5,280 shares of the company’s stock worth $548,000 after purchasing an additional 153 shares during the period. Finally, World Investment Advisors LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $752,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Down 0.8 %

Shares of NYSE CL opened at $94.73 on Tuesday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market cap of $76.83 billion, a PE ratio of 26.91, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The business has a fifty day moving average of $91.47 and a two-hundred day moving average of $92.28.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 earnings per share. As a group, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.09%.

Colgate-Palmolive announced that its board has approved a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research report on Wednesday, April 2nd. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, April 11th. UBS Group increased their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the company a “buy” rating in a report on Thursday, April 17th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $102.17.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.